ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 161 filers reported holding ARCUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $328,952 | -11.6% | 18,321 | +0.0% | 0.00% | – |
| Q2 2023 | $371,928 | +11.2% | 18,317 | -0.1% | 0.00% | – |
| Q1 2023 | $334,450 | +60.0% | 18,341 | +129.2% | 0.00% | – |
| Q3 2022 | $209,000 | +2.0% | 8,002 | -1.2% | 0.00% | – |
| Q2 2022 | $205,000 | -18.7% | 8,096 | +1.5% | 0.00% | – |
| Q1 2022 | $252,000 | -22.0% | 7,974 | -0.1% | 0.00% | – |
| Q4 2021 | $323,000 | -89.2% | 7,981 | -97.3% | 0.00% | -100.0% |
| Q4 2019 | $2,990,000 | -34.4% | 296,000 | -40.9% | 0.00% | 0.0% |
| Q3 2019 | $4,556,000 | +12.9% | 500,654 | -1.4% | 0.00% | 0.0% |
| Q2 2019 | $4,035,000 | -36.3% | 507,529 | +0.1% | 0.00% | -50.0% |
| Q1 2019 | $6,331,000 | +15.9% | 506,848 | -0.1% | 0.00% | +33.3% |
| Q4 2018 | $5,463,000 | -16.7% | 507,239 | +7.9% | 0.00% | -25.0% |
| Q3 2018 | $6,556,000 | +14.1% | 470,302 | +0.2% | 0.00% | +33.3% |
| Q2 2018 | $5,747,000 | -20.6% | 469,515 | +0.2% | 0.00% | -25.0% |
| Q1 2018 | $7,235,000 | – | 468,587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |